Hikma Pharmaceutical | HIK - Assets


Hikma Pharmaceutical reported $5.67B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Almirall EUR 2.37B 29.97M Jun/2026
argenx SE USD 10.03B 1.35B Jun/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
Autolus Therapeutics Ltd USD 527.06M 62M Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Fresenius EUR 42.37B 975M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lakefront Biotherapeutics EUR 3.37B 34.09M Mar/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 53.07B 1.54B Mar/2026
Orion EUR 1.87B 205.5M Jun/2026
Recordati EUR 5.37B 33.76M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
UCB EUR 18.16B 971M Dec/2025